Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Chipman

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2014
Recent BRCAPRO upgrades significantly improve calibrationEmanuele Mazzola, Jonathan Chipman, Su-Chun Cheng, et al.
Breast Cancer Research and Treatment|June 25, 2013
Providing access to risk prediction tools via the HL7 XML-formatted risk web serviceJonathan Chipman, Brian Drohan, Amanda Blackford, et al.
JTO Clinical and Research Reports|March 4, 2022
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice PatternKathleen Kerrigan, Yeonjung Jo, Jonathan Chipman, et al.
Breast Cancer Research and Treatment|January 21, 2016
A two-stage approach to genetic risk assessment in primary careSwati Biswas, Philamer Atienza, Jonathan Chipman, et al.
Statistics in Medicine|November 21, 2017
Authors' response to commentsMichael J Pencina, Jonathan Chipman, Ewout W Steyerberg, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 2026
Use of hypofractionation among underserved populations undergoing radiotherapy for cancer: Implications for policyNicole Z Murray, Joshua Sokeye, Joshua J Horns, et al.
Gynecologic Oncology|June 7, 2021
Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-upAnthony C Casper, Matthew W Parsons, Jonathan Chipman, et al.
Environmental Research|December 28, 2020
Patterns in forage fish mercury concentrations across Northeast US estuariesKate L Buckman, Robert P Mason, Emily Seelen, et al.
Breast Cancer Research and Treatment|May 22, 2013
Simplifying clinical use of the genetic risk prediction model BRCAPROSwati Biswas, Philamer Atienza, Jonathan Chipman, et al.
BMJ Open|March 28, 2018
Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within the veterans health administrationCaroline A Presley, Jea Young Min, Jonathan Chipman, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2014
Recent BRCAPRO upgrades significantly improve calibrationEmanuele Mazzola, Jonathan Chipman, Su-Chun Cheng, et al.
Breast Cancer Research and Treatment|June 25, 2013
Providing access to risk prediction tools via the HL7 XML-formatted risk web serviceJonathan Chipman, Brian Drohan, Amanda Blackford, et al.
JTO Clinical and Research Reports|March 4, 2022
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice PatternKathleen Kerrigan, Yeonjung Jo, Jonathan Chipman, et al.
Breast Cancer Research and Treatment|January 21, 2016
A two-stage approach to genetic risk assessment in primary careSwati Biswas, Philamer Atienza, Jonathan Chipman, et al.
Statistics in Medicine|November 21, 2017
Authors' response to commentsMichael J Pencina, Jonathan Chipman, Ewout W Steyerberg, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 2026
Use of hypofractionation among underserved populations undergoing radiotherapy for cancer: Implications for policyNicole Z Murray, Joshua Sokeye, Joshua J Horns, et al.
Gynecologic Oncology|June 7, 2021
Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-upAnthony C Casper, Matthew W Parsons, Jonathan Chipman, et al.
Environmental Research|December 28, 2020
Patterns in forage fish mercury concentrations across Northeast US estuariesKate L Buckman, Robert P Mason, Emily Seelen, et al.
Breast Cancer Research and Treatment|May 22, 2013
Simplifying clinical use of the genetic risk prediction model BRCAPROSwati Biswas, Philamer Atienza, Jonathan Chipman, et al.
BMJ Open|March 28, 2018
Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within the veterans health administrationCaroline A Presley, Jea Young Min, Jonathan Chipman, et al.
Pageof 5